Live Breaking News & Updates on Iovance Biotherapeutics

Stay updated with breaking news from Iovance biotherapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HC Wainwright Reiterates "Buy" Rating for Iovance Biotherapeutics (NASDAQ:IOVA)

HC Wainwright Reiterates "Buy" Rating for Iovance Biotherapeutics (NASDAQ:IOVA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Iovance-biotherapeutics , Avoro-capital-advisors , Artisan-partners-limited-partnership , Pricet-rowe-associates-inc , Iovance-biotherapeutics-inc , Vanguard-group-inc , Iovance-biotherapeutics-company-profile , Wells-fargo-company , Goldman-sachs-group , Get-free-report , Capital-advisors

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Average Rating of "Buy" by Analysts

Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have received a consensus rating of “Buy” from the ten analysts that are covering the stock, MarketBeat reports. Ten analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have updated their coverage on the stock in […] ....

United-states , Piper-sandler , Iovance-biotherapeutics , Avoro-capital-advisors , Goldman-sachs-group , Nasdaq , Barclays , Iovance-biotherapeutics-inc , Artisan-partners-limited-partnership , Vanguard-group-inc , Wells-fargo-company , Pricet-rowe-associates-inc

Brokerages Set Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Price Target at $24.64

Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have earned a consensus rating of “Buy” from the ten brokerages that are covering the company, MarketBeat Ratings reports. Ten investment analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the […] ....

United-states , Iovance-biotherapeutics , Iovance-biotherapeutics-company-profile , Goldman-sachs-group , Avoro-capital-advisors , Pricet-rowe-associates-inc , Iovance-biotherapeutics-inc , Barclays , Nasdaq , Vanguard-group-inc , Norges-bank , Wells-fargo-company

What Makes e.l.f. Beauty (ELF) an Investment Bet?

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. ....

India , United-states , America , Iovance-biotherapeutics , Microsoft , Beauty-inc , Artisan-small-cap-fund , Artisan-partners , Small-cap , Investor-class , Advisor-class , Institutional-class

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Shares Sold by Artisan Partners Limited Partnership

Artisan Partners Limited Partnership lessened its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 4.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,827,670 shares of the biotechnology company’s stock after selling 208,809 shares during the quarter. Artisan Partners Limited Partnership owned […] ....

United-states , Iovance-biotherapeutics , Piper-sandler , Nasdaq , Artisan-partners-limited-partnership , Corient-private-wealth , Goldman-sachs-group , Norges-bank , Roanoke-asset-management-corp , Investment-partners , Iovance-biotherapeutics-inc , Free-report